ISSN: 2047-4873
Journal Home
Journal Guideline
European Journal of Preventive Cardiology Q1 Unclaimed
European Journal of Preventive Cardiology is a journal indexed in SJR in Epidemiology and Cardiology and Cardiovascular Medicine with an H index of 130. It has an SJR impact factor of 2,119 and it has a best quartile of Q1. It has an SJR impact factor of 2,119.
European Journal of Preventive Cardiology focuses its scope in these topics and keywords: heart, exercise, risk, cardiovascular, rehabilitation, training, cardiac, coronary, disease, prescription, ...
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
2,119
SJR Impact factor130
H Index369
Total Docs (Last Year)1194
Total Docs (3 years)9651
Total Refs4566
Total Cites (3 years)676
Citable Docs (3 years)3.91
Cites/Doc (2 years)26.15
Ref/DocOther journals with similar parameters
MMWR. Morbidity and mortality weekly report Q1
Clinical Microbiology Reviews Q1
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control Q1
The Lancet HIV Q1
Journal of the American Society of Nephrology : JASN Q1
Compare this journals
Aims and Scope
Best articles by citations
The impact of social deprivation on coronary revascularisation treatment outcomes within the National Health Service in England and Wales
View moreA novel strategy for evaluating tilt test in athletes with syncope
View moreIntegrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
View moreTriggering of acute myocardial infarction by different means of transportation
View moreCardiac troponins: Potential biomarkers for the detection of subclinical coronary artery disease in athletes participating in endurance sports
View moreSafety and efficacy of aerobic exercise commenced early after cardiac surgery: A systematic review and meta-analysis
View moreProlonged hypothalamic-pituitary-adrenal axis activation after acute coronary syndrome in the GENESIS-PRAXY cohort
View moreLong-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome
View moreSevere infections and subsequent delayed cardiovascular disease
View moreGender differences in the prevalence, causes and treatment of high cardiovascular risk: findings from the FINRISK Survey
View moreQT interval, general mortality and the role of echocardiographic parameters of left ventricular hypertrophy: Results from the prospective, population-based CARLA study
View moreLDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial
View moreSafety and efficacy of cardiac rehabilitation for patients with continuous flow left ventricular assist devices
View morePredicting 10-year mortality in older adults using VO2max, oxygen uptake efficiency slope and frailty class
View moreAssessment of diet quality improves the classification ability of cardiovascular risk score in predicting future events: The 10-year follow-up of the ATTICA study (2002-2012)
View moreImportance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular risk factors: recommendations from the EACPR (Part II)
View moreLifestyle and risk factor management in people at high cardiovascular risk from Bulgaria, Croatia, Poland, Romania and the United Kingdom who participated in both the EUROASPIRE III and IV primary care surveys
View moreExercise stress test in apparently healthy individuals - where to place the finish line? The Ferrari corporate wellness programme experience
View moreEducational level and risk profile and risk control in patients with coronary heart disease
View moreComparison of trends in cardiovascular risk factors between two regions with and without a community and primary care prevention programme
View moreN-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives
View moreThe effect of regular aquatic exercise on blood pressure: A meta-analysis of randomized controlled trials
View moreBarriers and facilitators to participation in a health check for cardiometabolic diseases in primary care: A systematic review
View moreResponse to statin therapy in the real world
View more
Comments